Physical function, disease activity, and health-related quality-of-life outcomes after 3 years of adalimumab treatment in patients with ankylosing spondylitis
-
* Corresponding author: Désirée M van der Heijde d.vanderheijde@kpnplanet.nl
Arthritis Research & Therapy 2009, 11:R124 doi:10.1186/ar2790